newsfilter
← Latest News
GlobeNewswire·

NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results

– Marketing Authorization Applications for obicetrapib and FDC of obicetrapib plus ezetimibe accepted for review by European Medicines Agency – – BROOKLYN and BROADWAY pooled MACE analysis published in the Journal of